Prevalence and prognosis of respiratory muscle weakness in heart failure patients with preserved ejection fraction
Respiratory Medicine Feb 06, 2020
Hamazaki N, Kamiya K, Matsuzawa R, et al. - By performing a single-centre observational analysis, researchers determined if respiratory muscle weakness (RMW) can be used as a predictor of mortality in heart failure with reduced ejection fraction (HFrEF) patients. Consecutive 1,023 heart failure patients, including 445 in HFrEF and 578 in preserved ejection fraction (HFpEF), were examined. At hospital discharge, respiratory muscle strength was evaluated by measuring maximal inspiratory pressure (PImax). PImax <70% of predicted value defined RMW. All-cause death post-hospital discharge was the endpoint. In 39% of HFpEF patients, RMW was noted. Findings revealed an independent link of RMW with poor prognosis. Experts observed the additive influence of RMW on prognosis only in HFpEF but not in HFrEF.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries